Notification pursuant to List

RNS Number : 5226S

GlaxoSmithKline PLC

10 September 2010

 



Directorate Change

Further to the announcement made on 8 September 2010 regarding the appointment of Simon Dingemans as Executive Director and Chief Financial Officer Designate with effect from 4 January 2011, the Company confirms that there are no further disclosures to be made in accordance with Listing Rule 9.6.13R.

S M Bicknell

Company Secretary

10 September 2010

 

END

 

 

RDNSFSFISFSSESU